摘要
结核病(TB)是由结核杆菌(MTB)感染引起,其再次出现成为世界公众的主要健康问题。多重耐药性MTB菌株数量的增加 和最近越来越多关于普遍抗耐药性菌株病原体的出现,大大削弱了抗TB的治疗策略,漫长且暴露了期对于病人的毒性及其他副作用。搜索新的抗TB药物基本包括现存非专利和FDA已经批准的有机药物的再利用,现存有机药物类似物的改性旨在缩短和改善药物对疾病的治疗,或者搜寻新的抗分支杆菌的的可能作用机制。通过不同靶点生化途径疗法设计的机会,无机药物化学为有机药物化学提供了替代选择。潜在药物分子结构与金属铁离子的配合物为药物化学家提供了探索结构多样性的机会,可以利用多种金属的氧化形态,并且也通过其与金属中心的配位,为增强已确定有机药物的活性提供可能性。本综述中我们概括了目前对金属配合物抗结核能力的了解,他们的作用机制并推测了关于他们的潜在临床应用。
关键词: 抗结核分枝杆菌活性,抗结核活性,无机药物化学,金属配合物,结核分枝杆菌
Current Medicinal Chemistry
Title:Tuberculosis: An Inorganic Medicinal Chemistry Perspective
Volume: 22 Issue: 18
Author(s): Livia Viganor, Ciaran Skerry, Malachy McCann and Michael Devereux
Affiliation:
关键词: 抗结核分枝杆菌活性,抗结核活性,无机药物化学,金属配合物,结核分枝杆菌
摘要: Tuberculosis (TB) which is caused by the resilient pathogen Mycobacterium tuberculosis (MTB) has re-emerged to become a leading public health problem in the world. The growing number of multi-drug resistant MTB strains and the more recently emerging problem with the extensively drug resistant strains of the pathogen are greatly undermining conventional anti-TB therapeutic strategies which are lengthy and expose patients to toxicity and other unwanted side effects. The search for new anti-TB drugs essentially involves either the repurposing of existing organic drugs which are now off patent and already FDA approved, the synthesis of modified analogues of existing organic drugs, with the aim of shortening and improving drug treatment for the disease, or the search for novel structures that offer the possibility of new mechanisms of action against the mycobacterium. Inorganic medicinal chemistry offers an alternative to organic drugs through opportunities for the design of therapeutics that target different biochemical pathways. The incorporation of metal ions into the molecular structure of a potential drug offers the medicinal chemist an opportunity to exploit structural diversity, have access to various oxidation states of the metal and also offer the possibility of enhancing the activity of an established organic drug through its coordination to the metal centre. In this review, we summarize what is currently known about the antitubercular capability of metal complexes, their mechanisms of action and speculate on their potential applications in the clinic.
Export Options
About this article
Cite this article as:
Livia Viganor, Ciaran Skerry, Malachy McCann and Michael Devereux , Tuberculosis: An Inorganic Medicinal Chemistry Perspective, Current Medicinal Chemistry 2015; 22 (18) . https://dx.doi.org/10.2174/0929867322666150408112357
DOI https://dx.doi.org/10.2174/0929867322666150408112357 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhibition of Shikimate Kinase and Type II Dehydroquinase for Antibiotic Discovery: Structure-Based Design and Simulation Studies
Current Topics in Medicinal Chemistry Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review
Current Pharmaceutical Design Determining Partition Coefficient (Log P), Distribution Coefficient (Log D) and Ionization Constant (pKa) in Early Drug Discovery
Combinatorial Chemistry & High Throughput Screening Privileged Structures in the Design of Potential Drug Candidates for Neglected Diseases
Current Medicinal Chemistry CAPi: Computational Model for Apicoplast Inhibitors Prediction Against Plasmodium Parasite
Current Computer-Aided Drug Design Green and Sustainable Technology: Efficient Strategy for the Synthesis of Biologically Active Pyrimidine Derivatives
Current Organocatalysis Current Understanding of the Role of Dendritic Cells and Their Co-Stimulatory Molecules in Generating Efficient T Cell Responses in Lepromatous Leprosy
Current Immunology Reviews (Discontinued) Antimycobacterial Assessment and Microwave-assisted Synthesis of 2-aryl- 3-(4-methylphenylamino)thiazolidin-4-one Derivatives
Letters in Organic Chemistry Discovery of New Potential Antimalarial Compounds Using Virtual Screening of ZINC Database
Combinatorial Chemistry & High Throughput Screening Novel Azole-Functionalited Flouroquinolone Hybrids: Design, Conventional and Microwave Irradiated Synthesis, Evaluation as Antibacterial and Antioxidant Agents
Letters in Drug Design & Discovery Chemoinformatics Approach for Building Molecular Networks from Marine Organisms
Combinatorial Chemistry & High Throughput Screening Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery Visual and Quantitative Assessment of COVID-19 Pneumonia on Chest CT: The Relationship with Disease Severity and Clinical Findings
Current Medical Imaging Biomarkers in the Exhaled Breath Condensate of Healthy Adults: Mapping the Path Towards Reference Values
Current Medicinal Chemistry Invasive Pulmonary Aspergillosis in Acute Leukemia: Current Issues for Pathogenesis, Diagnosis and Treatment
Current Respiratory Medicine Reviews Marine Products with Anti-Protozoal Activity: A Review
Current Clinical Pharmacology Interleukin 10 in Antiviral Responses
Current Immunology Reviews (Discontinued) Induction of Cytochromes P450
Current Drug Metabolism DprE1 - from the Discovery to the Promising Tuberculosis Drug Target
Current Pharmaceutical Design Integrase Strand Transfer Inhibitors and the Emergence of Immune Reconstitution Inflammatory Syndrome (IRIS)
Current HIV Research